BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22258929)

  • 1. Antiviral applications of Toll-like receptor agonists.
    Horscroft NJ; Pryde DC; Bright H
    J Antimicrob Chemother; 2012 Apr; 67(4):789-801. PubMed ID: 22258929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of endosomal TLR agonists in viral disease.
    Averett DR; Fletcher SP; Li W; Webber SE; Appleman JR
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1468-72. PubMed ID: 18031247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in Toll-like receptor targeted therapeutics.
    Connolly DJ; O'Neill LA
    Curr Opin Pharmacol; 2012 Aug; 12(4):510-8. PubMed ID: 22748800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents.
    Baldridge JR; McGowan P; Evans JT; Cluff C; Mossman S; Johnson D; Persing D
    Expert Opin Biol Ther; 2004 Jul; 4(7):1129-38. PubMed ID: 15268679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
    Thomas A; Laxton C; Rodman J; Myangar N; Horscroft N; Parkinson T
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2969-78. PubMed ID: 17548497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and innate antiviral immunity.
    Galiana-Arnoux D; Imler JL
    Tissue Antigens; 2006 Apr; 67(4):267-76. PubMed ID: 16634862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modulation of the host toll-like receptor signaling pathways by virus infection].
    Jing ZZ; He XB; Fang YX; Jia HJ; Zhou T
    Bing Du Xue Bao; 2012 Jun; 28(4):453-61. PubMed ID: 22978173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling.
    Gosu V; Basith S; Kwon OP; Choi S
    Molecules; 2012 Nov; 17(11):13503-29. PubMed ID: 23151919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Antiviral Therapies Targeting Toll-like Receptors.
    Shah M; Anwar MA; Kim JH; Choi S
    Expert Opin Investig Drugs; 2016; 25(4):437-53. PubMed ID: 26878224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Self or non-self RNA sensing mechanism of innate antiviral immunity].
    Onoguchi K; Yoneyama M
    Tanpakushitsu Kakusan Koso; 2009 Dec; 54(16 Suppl):2226-32. PubMed ID: 21089645
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of toll-like receptor therapeutics.
    Parkinson T
    Curr Opin Mol Ther; 2008 Feb; 10(1):21-31. PubMed ID: 18228178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine adjuvant activity of 3M-052: an imidazoquinoline designed for local activity without systemic cytokine induction.
    Smirnov D; Schmidt JJ; Capecchi JT; Wightman PD
    Vaccine; 2011 Jul; 29(33):5434-42. PubMed ID: 21641953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity.
    Bowie AG
    Clin Exp Immunol; 2007 Feb; 147(2):217-26. PubMed ID: 17223961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic and therapeutic implications of toll-like receptor ligands.
    Hedayat M; Takeda K; Rezaei N
    Med Res Rev; 2012 Mar; 32(2):294-325. PubMed ID: 22383179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
    McDonald DR; Brown D; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of induction and action of interferons.
    Content J
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):51-71. PubMed ID: 19739398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 and the resolution of infections.
    Filippi CM; von Herrath MG
    J Pathol; 2008 Jan; 214(2):224-30. PubMed ID: 18161757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.